.popover-content { display: none; position: absolute; }

Free Article[](#)

You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to **get instant access to our top analyst recommendations, in-depth research, investing resources,** and more. [Learn More](https://www.fool.com/mms/mark/op-free-tbox-art)

Prediction: CRISPR Therapeutics Will Beat the Market. Here's Why
================================================================

By [Motley Fool YouTube](/author/20641/) – Feb 28, 2025 at 7:00PM

[NASDAQ: CRSP](/quote/nasdaq/crsp/)
-----------------------------------

### CRISPR Therapeutics

![CRISPR Therapeutics Stock Quote](https://g.foolcdn.com/art/companylogos/mark/CRSP.png)

Market Cap

$4B

Today's Change

Arrow-Thin-Down

(0.69%) $0.30

Current Price

$43.92

Price as of February 28, 2025, 4:00 p.m. ET

Explore the exciting world of **CRISPR Therapeutics** ([CRSP](/quote/nasdaq/crsp/) 0.69%) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!  
  
_\*Stock prices used were the prices of Jan. 29, 2025. The video was published on Feb. 28, 2025._  

  
  

_[Karl Thiel](https://www.fool.com/author/1337/) has no position in any of the stocks mentioned. [Keith Speights](https://www.fool.com/author/2035/) has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends CRISPR Therapeutics. The Motley Fool has a [disclosure policy](https://www.fool.com/legal/fool-disclosure-policy/)._

Related Articles

[![scientist altering DNA genome project](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F807529%2Fscientist-altering-dna-genome-project.jpg&op=resize&w=92&h=52)

2 Beaten-Down Stocks to Buy Before They Soar by 66% and 415%, According to Wall Street

](/investing/2025/02/24/2-beaten-down-stocks-to-buy-before-they-soar-by-66/)[![Person in a lab gazing into a microscope](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F807531%2Fperson-in-a-lab-gazing-into-a-microscope.jpg&op=resize&w=92&h=52)

Why CRISPR Therapeutics Stock Was a Massive Winner on Wednesday

](/investing/2025/02/12/why-crispr-therapeutics-stock-was-a-massive-winner/)[![scientist altering DNA genome project](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F806140%2Fscientist-altering-dna-genome-project.jpg&op=resize&w=92&h=52)

Investing $1,000 in These 3 Beaten-Down Stocks Could Be a Brilliant Move

](/investing/2025/02/10/investing-1000-in-these-3-beaten-down-stocks-could/)[![scientist altering DNA genome project](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F802593%2Fscientist-altering-dna-genome-project.jpg&op=resize&w=92&h=52)

2 Magnificent Stocks to Buy That Are Near Their 52-Week Lows

](/investing/2025/01/16/2-magnificent-stocks-to-buy-that-are-near-their-52/)[![investor-making-stock-decision-getty](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F803774%2Finvestor-making-stock-decision-getty.jpg&op=resize&w=92&h=52)

Meet the Innovative Growth Stock That Could Rocket 114% to 152% Higher in 2025, According to a Couple of Wall Street Analysts

](/investing/2025/01/14/meet-the-innovative-growth-stock-that-could-rocket/)

890%